BD 256038 - BD Veritor RSV Test CLIA Waived 30/Bx, 12 BX/CA
The BD 256038 BD Veritor RSV Test is a rapid, CLIA waived in vitro diagnostic assay designed for the qualitative detection of Respiratory Syncytial Virus antigens. Intended for use with the BD Veritor Plus System, this test delivers fast, objective results to support timely clinical decision-making. The system combines simple specimen handling with digital result interpretation, helping reduce subjectivity and streamline respiratory testing workflows in point-of-care settings.
| Manufacturer | 256038 |
| Application | Respiratory Test Kit |
| CLIA Classification | CLIA Waived |
| CLIA Classified | CLIA Waived |
| Purchase Program Type | Standard Purchase |
| Reading Type | Machine Read |
| Specialty | Immunoassay |
Key Benefits
Rapid time to results supports earlier diagnosis and treatment decisions, improving patient flow and care efficiency. CLIA waived status enables testing in a wide range of point-of-care environments without the complexity of moderate or high complexity laboratory requirements. Digital result interpretation through the BD Veritor Plus Analyzer reduces reading variability and enhances result confidence. The streamlined workflow minimizes hands-on time and supports consistent testing across staff.
Compatibility and Applications
This RSV test is designed for use with the BD Veritor Plus System and compatible specimen collection devices as specified by BD. It is commonly used in physician offices, urgent care centers, pediatric clinics, emergency departments, and outpatient settings. Typical applications include evaluation of patients presenting with respiratory symptoms where rapid RSV identification is clinically valuable.
Usage Guidelines
Collect the patient specimen according to approved collection procedures and prepare the sample following the test instructions. Insert the test device into the BD Veritor Plus Analyzer as directed. Results are displayed digitally within the specified time frame. Dispose of used test components according to biohazard and facility protocols.
Certifications, Safety Standards, and Regulatory Approvals
The BD Veritor RSV Test is CLIA waived and cleared for use in point-of-care settings in accordance with applicable FDA regulations for in vitro diagnostic devices. It is manufactured under BDs quality management systems to ensure consistent performance, reliability, and regulatory compliance.
Comparison with Competitor Products
Compared to visually read rapid RSV tests, the BD Veritor system provides objective, instrument-read results that reduce interpretation variability. Many alternative rapid tests rely on subjective visual assessment, which can increase inconsistency. BDs integrated analyzer and test design support standardized results and improved workflow efficiency.
Typical User Profile and Application Scenarios
This test is used by physicians, nurses, medical assistants, and clinical staff performing point-of-care diagnostics. It is particularly well suited for pediatric and family practice settings, urgent care clinics, and emergency departments during respiratory virus season.
Best Practices for Use and Maintenance
Store test kits and components according to manufacturer recommendations. Use only approved specimen types and follow timing requirements precisely. Ensure the BD Veritor Plus Analyzer is maintained and calibrated per facility guidelines. Do not use expired test kits.
Regulatory and Safety Information
This product is intended for professional point-of-care use only. Follow all instructions for use, biosafety precautions, and disposal requirements for potentially infectious materials. Compliance with CLIA waived testing requirements and institutional policies is essential for safe and effective operation.
How to Order
To order the BD 256038 BD Veritor RSV Test, CLIA Waived, add the product to your cart and complete the secure checkout process on the CIA Medical website. For bulk diagnostic purchasing, analyzer compatibility questions, or assistance selecting respiratory testing solutions, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.
